{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:19:54Z","timestamp":1794899994200,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Special Science Research Foundation of Sichuan Administration of traditional Chinese Medicine of China","award":["No.2021MS373"],"award-info":[{"award-number":["No.2021MS373"]}]},{"name":"Research Fundation of Panzhihua Medical Research Center","award":["PYYZ-2023-03"],"award-info":[{"award-number":["PYYZ-2023-03"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study investigates the efficacy and mechanism of a Chinese herbal enema prescription (CHEP) in improving renal function and delaying progression to dialysis in patients with chronic kidney disease (stage 3\u20135) before dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 102 patients (mean age: 47.6\u2005\u00b1\u200512.3 years; male: 46.15%) satisfying the inclusion criteria were randomized into control or experimental groups. Patients in the experimental group received retention enema using CHEP in addition to standard Western medical treatment, whereas patients in the control group only received standard Western medical treatment, 2-week intervention period. Changes in traditional Chinese medicine (TCM) symptom scores (a composite score based on the severity and frequency of TCM-defined symptoms such as fatigue, anorexia, and edema), renal function (serum creatinine [SCr], uric acid, blood urea nitrogen, microinflammatory C-reactive protein [CRP]), enterogenous uremic toxins (trimethylamine oxide [TMAO], indoxyl sulfate), and intestinal barrier function (endotoxin [ET], d-Lactate [DL], and diamine oxidase [DAO]) before and after treatment in both groups were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After treatment, the TCM symptom scores of both groups decreased compared to those before treatment. Moreover, the difference in the scores of the experimental group pre- versus post- treatment was significantly greater than that of the control group (standardized mean difference [SMD]\u2005=\u2005\u22121.79, 95% confidence interval [CI] = \u22122.56 to 1.02) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01).The total effective rate based on TCM symptom improvement was 73.3% in the control group and 91.3% in the experimental group (odds ratio\u2005=\u20052.34, 95% CI = 1.56\u20134.28) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Concentrations of SCr and blood urea nitrogen were significantly lower (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) in CHEP versus control at the end of treatment; however, there were no significant differences in uric acid, estimated glomerular filtration rate (eGFR), and CRP (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). The levels of DL (SMD\u2005=\u200584.11, 95% CI = 10.65\u2013162.21), DAO (SMD\u2005=\u200514.08, 95% CI = 2.33\u201327.41), and ET (SMD\u2005=\u200537.27, 95% CI = 9.31\u201365.50) in the experimental group after treatment showed significant differences (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). The indoxyl sulfate (SMD [95%] CI = 16.11 [1.22\u201333.11]) and TMAO (SMD [95%] CI = 8.13 (1.26\u201315.86)] in the experimental group after treatment were significantly lower compared to the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CHEP can enhance the clinical function and delay the decline of kidney function in patients with chronic kidney disease (stage 3\u20135), mainly by promoting the excretion of enterogenic uremic toxins and improving intestinal barrier function to delay renal function progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043791","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:00:40Z","timestamp":1755198040000},"page":"e43791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Chinese herbal enema prescription on renal function, enterogenous uremic toxins and intestinal barrier function in stage 3 to 5 chronic kidney disease predialysis participants: A randomized controlled trial"],"prefix":"10.1097","volume":"104","author":[{"given":"Xue","family":"Ru","sequence":"first","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, School of Biological and Chemical Engineering, Panzhihua University, Panzhihua, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3861-7441","authenticated-orcid":false,"given":"Tao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China"},{"name":"Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge.","volume":"365","author":"El Nahas","year":"2005","journal-title":"Lancet"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.2021.4807","article-title":"Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial.","volume":"325","author":"Ogata","year":"2021","journal-title":"JAMA"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"e150112","DOI":"10.1172\/jci.insight.150112","article-title":"Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis.","volume":"6","author":"Brightwell","year":"2021","journal-title":"JCI Insight"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) foreword.","volume":"7","author":"Wheeler","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1080\/10408398.2021.1996331","article-title":"Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: a focus on dietary fibers.","volume":"63","author":"Melekoglu","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1900\/RDS.2019.15.35","article-title":"Impact of physical exercise on gut microbiome, inflammation, and the pathobiology of metabolic disorders.","volume":"15","author":"Sohail","year":"2019","journal-title":"ev Diabet Stud"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"e108448","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS One"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end\u2010stage renal disease patients.","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1681\/ASN.2015111285","article-title":"Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD\u2013related systemic inflammation.","volume":"28","author":"Andersen","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome.","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cvsm.2016.06.005","article-title":"Controversies in veterinary nephrology: renal diets are indicated for cats with international renal interest society chronic kidney disease stages 2 to 4: the pro view.","volume":"46","author":"Polzin","year":"2016","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/jtd-23-402","article-title":"Chinese herbal injections plus Western medicine on inflammatory factors for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis.","volume":"15","author":"Zhu","year":"2023","journal-title":"J Thorac Dis"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"F375","DOI":"10.1152\/ajprenal.00266.2016","article-title":"A perspective on chronic kidney disease progression.","volume":"312","author":"Zhong","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-20261117","first-page":"2425","article-title":"Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine.","volume":"42","author":"Han","year":"2017","journal-title":"Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China J Chin Materia Medica"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"e27748","DOI":"10.1097\/MD.0000000000027748","article-title":"Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: a protocol of a randomized controlled trial.","volume":"100","author":"Mei","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R18-20261117","first-page":"205","article-title":"Research progress in the treatment of diabetic kidney disease with Chinese medicine enema.","volume":"8","author":"Wu","year":"2021","journal-title":"J Tradit Chin Med Sci"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"e20234","DOI":"10.1097\/MD.0000000000020234","article-title":"Clinical trial for conventional medicine integrated with traditional Chinese medicine (TCM) in the treatment of patients with chronic kidney disease.","volume":"99","author":"Xi","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2016060656","article-title":"Constipation and incident CKD.","volume":"28","author":"Sumida","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11655-013-1351-8","article-title":"Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine.","volume":"19","author":"Zou","year":"2013","journal-title":"Chin J Integr Med"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21037\/atm-21-871","article-title":"Effectiveness of Chinese herbal medicine combined with Western medicine on deferring dialysis initiation for nondialysis chronic kidney disease stage 5 patients: a multicenter prospective nonrandomized controlled study.","volume":"9","author":"Wu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.18632\/oncotarget.8160","article-title":"Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"R24-20261117","first-page":"10","article-title":"Clinical effect of rhubarb on the treatment of chronic renal failure: a meta-analysis.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"111921","DOI":"10.1016\/j.jep.2019.111921","article-title":"Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: an updated systematic review and meta-analysis.","volume":"239","author":"Zhang","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"R26-20261117","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/gmic.27492","article-title":"A novel SCFA receptor, the microbiota, and blood pressure regulation.","volume":"5","author":"Pluznick","year":"2014","journal-title":"Gut Microbes"},{"key":"R27-20261117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physiolgenomics.00136.2014","article-title":"Evidence for a link between gut microbiota and hypertension in the Dahl rat.","volume":"47","author":"Mell","year":"2015","journal-title":"Physiol Genomics"},{"key":"R28-20261117","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","article-title":"The leaky gut and altered microbiome in chronic kidney disease.","volume":"27","author":"Lau","year":"2017","journal-title":"J Renal Nutr"},{"key":"R29-20261117","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-16-2929","article-title":"The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologistshost microbiome in human health.","volume":"77","author":"Thomas","year":"2017","journal-title":"Cancer Res"},{"key":"R30-20261117","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","article-title":"Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.","volume":"59","author":"Shi","year":"2014","journal-title":"Dig Dis Sci"},{"key":"R31-20261117","first-page":"17","article-title":"Effects of high flux hemodialysis on cardiac function and levels of IL-6, IL-8 and TNF-alpha in end-stage renal disease patients.","volume":"26","author":"Xuan","year":"2020","journal-title":"J Hainan Med College"},{"key":"R32-20261117","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.3390\/nu14214699","article-title":"Direct action of non-digestible oligosaccharides against a leaky gut.","volume":"14","author":"Mavrogeni","year":"2022","journal-title":"Nutrients"},{"key":"R33-20261117","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/acs.jafc.9b00080","article-title":"Intestinal barrier function\u2013non-alcoholic fatty liver disease interactions and possible role of gut microbiota.","volume":"67","author":"Cui","year":"2019","journal-title":"J Agric Food Chem"},{"key":"R34-20261117","doi-asserted-by":"crossref","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson\u2019s disease is associated with gut dysbiosis: two-year follow-up study.","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"key":"R35-20261117","doi-asserted-by":"crossref","first-page":"104652","DOI":"10.1016\/j.micpath.2020.104652","article-title":"Current progress of research on intestinal bacterial translocation.","volume":"152","author":"Wang","year":"2021","journal-title":"Microb Pathog"},{"key":"R36-20261117","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3892\/etm.2016.3468","article-title":"Glutamine decreases intestinal mucosal injury in a rat model of intestinal ischemia-reperfusion by downregulating HMGB1 and inflammatory cytokine expression.","volume":"12","author":"Shu","year":"2016","journal-title":"Exp Ther Med"},{"key":"R37-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline.","volume":"17","author":"Spahn","year":"2013","journal-title":"Critical Care"},{"key":"R38-20261117","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3748\/wjg.v19.i4.492","article-title":"Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury.","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R39-20261117","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00795-013-0055-7","article-title":"Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats.","volume":"47","author":"Fukudome","year":"2014","journal-title":"Med Mol Morphol"},{"key":"R40-20261117","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/toxins12110684","article-title":"Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease.","volume":"12","author":"Cheng","year":"2020","journal-title":"Toxins"},{"key":"R41-20261117","doi-asserted-by":"crossref","first-page":"e005022","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease.","volume":"6","author":"Hung","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R42-20261117","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins.","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R43-20261117","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/jcm8091424","article-title":"Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika Study).","volume":"8","author":"Di Iorio","year":"2019","journal-title":"J Clin Med"},{"key":"R44-20261117","doi-asserted-by":"crossref","first-page":"913","DOI":"10.17219\/acem\/147666","article-title":"Trimethylamine N-oxide in cardiovascular disease.","volume":"31","author":"Konieczny","year":"2022","journal-title":"Adv Clin Exp Med"},{"key":"R45-20261117","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int"},{"key":"R46-20261117","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11255-020-02632-6","article-title":"Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.","volume":"53","author":"Guo","year":"2021","journal-title":"Int Urol Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:42Z","timestamp":1794898902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":44,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043791","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2023-09-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}